Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,633.10
+50.20 (1.94%)
Nov 9, 2026, 12:32 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.09 trillion as of November 6, 2026. It is the 1,967th most valuable company in the world and the 112th biggest in India. Its market cap has increased by 16.50% in one year.
Market Cap
1.09T
Enterprise Value
1.12T
Revenue
153.79B
Global Rank
Country Rank
#112 India
PE Ratio
48.54
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.09T, an increase of 90.89%. That is a compound annual growth rate of 20.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 1.09T | 19.95% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.74T |
| Laurus Labs | 1.26T |
| Zydus Lifesciences | 1.19T |
| Cipla | 1.14T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 730.90B |
| Alkem Laboratories | 633.34B |
| Gland Pharma | 522.88B |